Deaconess Clinic

Evansville, Indiana 47725

0 studies enrolling now · 18 studies all time

What they study most

Acute Gout, Asthma, Aspirin-Induced, Atopic Dermatitis, Behavioral Measures of Tolerance, Coronary Heart Disease (CHD), Diabetes Mellitus, Type 2, Dyslipidemia, Episodic Migraine, Lymphoma, Follicular, Major Depressive Disorder, Migraine, Non-small Cell Lung Cancer

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed
• Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis — Completed
• Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention — Completed
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed
• Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) — Completed
• Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer — Stopped early
• Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder — Completed
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria — Completed
• Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL) — Stopped early
• Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance — Completed
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients — Stopped early